The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2023

Filed:

Oct. 26, 2015
Applicant:

Koninklijke Philips N.v., Eindhoven, NL;

Inventors:

Hendrik Jan Van Ooijen, Eindhoven, NL;

Wilhelmus Franciscus Johannes Verhaegh, Eindhoven, NL;

Anne Godefrida Catharina Van Brussel, Eindhoven, NL;

Janneke Wrobel, Eindhoven, NL;

Robert Van Gog, Eindhoven, NL;

Assignee:

KONINKLIJKE PHILIPS N.V., Eindhoven, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 5/00 (2019.01); G16B 25/10 (2019.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16B 5/20 (2019.01); G16B 30/00 (2019.01); G16B 20/00 (2019.01); G16B 20/30 (2019.01); G16B 20/20 (2019.01); C12Q 1/6883 (2018.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
G16B 5/20 (2019.02); C12Q 1/6883 (2013.01); C12Q 1/6886 (2013.01); G16B 5/00 (2019.02); G16B 20/00 (2019.02); G16B 20/20 (2019.02); G16B 20/30 (2019.02); G16B 25/10 (2019.02); G16B 30/00 (2019.02); G16H 50/20 (2018.01); G16H 50/30 (2018.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01);
Abstract

A bioinformatics method for determining a risk score that indicates a risk that a subject will experience a negative clinical event within a certain period of time. The risk score is based on a combination of activities of two or more cellular signaling pathways in a subject, such as a human, wherein the specific cellular signaling pathways are the PI3K pathway and one or more of a Wnt pathway, an ER pathway, and an HH pathway. The invention also includes an apparatus with a digital processor configured to perform such a method, to a non-transitory storage medium storing instructions that are executable by a digital processing device to perform such a method, and to a computer program comprising program code means for causing a digital processing device to perform such a method. The invention achieves advanced prognosis of negative clinical events, for example, disease progression, recurrence, development of metastasis, or even death.


Find Patent Forward Citations

Loading…